2026-02-07 04:45:05
Latest Post
Fusion Finance Q3 FY26: Disbursements Surge 23% QoQ to ₹1,594 Cr, PAT Swings to ₹14 Cr Profit
Nifty Recovers 200 Points to End the Session Near Day high
Gateway Distriparks Q3 FY26: Revenue Soars 39% to ₹566 Cr, PAT Up 4% - Declares ₹2 Special Dividend on Debt-Free Milestone
Mamaearth Onboards Sreeleela as Hair Care Category Brand Ambassador; Unveils Valentine's Day Film for Rosemary Anti-Hair Fall Shampoo
Wanbury Limited Q3 FY26: PAT Explodes 1,194% YoY to ₹15.8 Cr, Revenue Up 22%
Stock Report
Ranbaxy promoters enter clinical research
Posted On : 2006-03-17 01:18:11( TIMEZONE : IST )
The promoters of Ranbaxy Laboratories have entered clinical research segment by setting up a contract research organisation (CRO) under the name of Fortis Clinical Research activities.
